Patent ID: 11932671
Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The polypeptide of claim 1, comprising:
i. A polypeptide having the amino acid sequence of SEQ ID NO: 45;
ii. SEQ ID NO: 45 modified by up to 5 single amino acid substitutions, deletions and/or insertions; and/or
iii. A polypeptide having the amino acid sequence SEQ ID NO: 44;
iv. SEQ ID NO: 44 modified by up to 5 single amino acid substitutions, deletions and/or insertions,
wherein the 5 single amino acid substitutions, deletions and/or insertions do not include amino acid positions V32, R123 and R126.